在接受化疗的癌症患者中过度活跃的膀症状
Margaret Lotz1,2, Sarah Keates1,2, Danielle Carr3
1Department of Hematology and Oncology, Mount Auburn Hospital, Cambridge.
American journal of clinical oncology
|July 3, 2025
概括
某些癌症治疗可能会导致过度活性膀 (OAB) 症状. 接受双重HER2向治疗 (特拉斯图祖马布和珀图祖马布) 的妇女在治疗期间报告了OAB症状增加和尿道不适.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗是癌症治疗的基石.
- 过度活跃的膀 (OAB) 是一种以尿急性为特征的疾病.
- 化疗和OAB之间的潜在联系需要进一步调查.
研究的目的:
- 研究化疗与女性癌症患者膀过活 (OAB) 的发展之间的关联.
- 评估特定的化疗方案是否有助于OAB症状.
主要方法:
- 这是一项前性纵向研究,涉及65名女性癌症患者.
- 患者在开始化疗之前和之后在多个时间点填写了关于膀症状的验证问卷.
- 数据收集发生在2017年至2023年之间.
主要成果:
- 在所有患者中,没有检测到OAB症状的整体显著增加.
- 用人类表皮生长因子受体-2 (HER2) 单克隆抗体治疗的患者显示出明显更高的OAB症状得分.
- 用trastuzumab和pertuzumab的双重治疗与增加尿路不适和生活质量变化有关.
结论:
- 双重针对HER2的治疗 (特拉斯图祖马布和珀图祖马布) 可能会增加HER2阳性乳腺癌女性OAB症状的风险.
- 医疗保健提供者应监测接受这种特定治疗的患者的尿路症状.
- 需要进一步的研究,以了解化疗引起的OAB的机制和管理.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
330
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
330
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
457
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
457
Nursing Assessment of the Genitourinary System I: Health History
82
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
82
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
43
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
43


